Physician profile
Matthew Partan
NPI 1558695999
$24,376.45
in general payments reported to CMS, 2019-2025
8 companies · $3,795 in 2025
The $3,795 reported for 2025 was more than what 79% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $19K · 2024: $1,569 · 2025: $3,795.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $19K · Travel and Lodging: $3,770 · Food and Beverage: $1,606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $19,000.00 |
| Travel and Lodging | $3,770.34 |
| Food and Beverage | $1,606.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $20,354.90 | 2023-2024 | |
| Smith+Nephew, INC. | $3,336.41 | 2024-2025 | Acufex Meniscal Root Repair, Q-Fix, Healicoil |
| Depuy Synthes Sales INC. | $365.28 | 2025 | Dynacord, Va-Lcp, Unium |
| Stryker Corporation | $215.45 | 2024-2025 | Blueprint Patient Specific Instrumentation, Aequalis Flex Revive, Aequalis Perform |
| Medical Device Business Services, INC. | $45.62 | 2025 | Na |
| Linvatec Corporation | $25.41 | 2025 | Biobrace 23mm |
| Vericel Corporation | $20.64 | 2024 | Maci |
| Polaris Technology Solutions LLC | $12.74 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Partan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.